Search results
Apple and Amazon Earnings, Fed Rate Decision, Jobs Data, and More to Watch This Week
Barrons.com· 8 hours agoWednesday’s highlights include CVS Health Etsy Mastercard Pfizer and Qualcomm Apple Booking Holdings...
FDA Green Lights Pfizer's Gene Therapy For Rare Bleeding Disorder Hemophilia
Benzinga via Yahoo Finance· 3 days agoFriday, the FDA approved Pfizer Inc’s (NYSE:PFE) Beqvez (fidanacogene elaparvovec-dzkt) for moderate...
13 Best Reddit Stocks to Buy Now
Insider Monkey via Yahoo Finance· 6 hours agoIn this article, we will take a detailed look at the 13 Best Reddit Stocks to Buy Now. For a quick overview of such stocks, read our article 5 Best...
Pfizer Shareholders Reject Political Spending, Lobbying Proposal
Bloomberg Law· 4 days agoPfizer investors dismissed a proposal that would have required the drugmaker to disclose how its political donations square with its publicly stated values, at the company ...
Pfizer Receives FDA Approval for Bleeding Disorder Treatment
Barrons.com· 3 days agoPfizer has received approval from the Food and Drug Administration for a rare genetic bleeding...
GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology
WSAU Wausau· 4 days agoBy Blake Brittain (Reuters) - GlaxoSmithKline sued Pfizer and BioNTech in Delaware federal court on...
Pfizer's Options: A Look at What the Big Money is Thinking - Pfizer (NYSE:PFE)
Benzinga· 3 days agoLoading... Loading... Deep-pocketed investors have adopted a bullish approach towards Pfizer PFE , and it's something market players shouldn't ignore. Our tracking of public ...
Pfizer and Levi Strauss Face Challenges from Conservative Shareholders Over Support of Divisive...
National Center for Public Policy Research· 5 days agoWashington, D.C. – At this week’s Pfizer and Levi Strauss annual shareholder meetings, shareholder...
Pfizer Wins FDA Approval For $3.5 Million Gene Therapy
Investor's Business Daily· 3 days agoPfizer won FDA approval for a new hemophilia B gene therapy, a rival to Hemgenix from CSL and Uniqure.
Biodexa gains license for polyposis asset as stock more than doubles
Pharmaceutical Technology via Yahoo Finance· 9 hours agoRapamycin first gained FDA approval in 1999 for treating organ rejection in renal transplantation,...